Technical / White Paper

Age-defining Eye Saviors: A new clinical study of XanMax®

Published

Format: PDF file | Document type: Technical / White Paper

Age-defining Eye Saviors: A new clinical study of XanMax®

A randomized, double blind, placebo controlled, parallel study has been recently conducted for a duration of 180 days in elderly volunteers.

Statistically significant results demonstrated that XanMax®​ supports healthy macula through deposition of optimal levels of carotenoid pigments.

Furthermore, the study also demonstrated that the formulation was safe and well tolerated when administrated orally.

XanMax®​ is an innovative formulation of Zeaxanthin in combination with Lutein which is available from natural Marigold flowers.

XanMax®​ is part of the Gee Lawson range of speciality ingredients, exclusively distributed in all Europe by LEHVOSS Group.

Related resources from Gee Lawson Nutritional - LEHVOSS Group

Show more

Supplier info centre